Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Shares Outstanding (Weighted Average) (2018 - 2025)

Viemed Healthcare's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $38.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.36% year-over-year to $38.9 million; the TTM value through Dec 2025 reached $38.9 million, changed 0.36%, while the annual FY2025 figure was $38.9 million, 0.36% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $38.9 million in Q4 2025 per VMD's latest filing, up from $38.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $39.6 million in Q1 2022 to a low of $38.2 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $38.9 million, with a median of $38.8 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 2.89% in 2021, then decreased 3.7% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $39.5 million in 2021, then fell by 2.12% to $38.7 million in 2022, then dropped by 0.78% to $38.4 million in 2023, then grew by 1.05% to $38.8 million in 2024, then rose by 0.36% to $38.9 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Shares Outstanding (Weighted Average) are $38.9 million (Q4 2025), $38.6 million (Q3 2025), and $39.5 million (Q2 2025).